These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11883710)

  • 41. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G; Schüle C; Baghai T; Kieser M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
    Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
    Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Undeclared exposure to St. John's Wort in hospitalized patients.
    Martin-Facklam M; Rieger K; Riedel KD; Burhenne J; Walter-Sack I; Haefeli WE
    Br J Clin Pharmacol; 2004 Oct; 58(4):437-41. PubMed ID: 15373938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrier.
    El Biali M; Wölfl-Duchek M; Jackwerth M; Mairinger S; Weber M; Bamminger K; Poschner S; Rausch I; Schindler N; Lozano IH; Jäger W; Nics L; Tournier N; Hacker M; Zeitlinger M; Bauer M; Langer O
    Clin Transl Sci; 2024 May; 17(5):e13804. PubMed ID: 38700454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of St. John's wort on free radical production.
    Hunt EJ; Lester CE; Lester EA; Tackett RL
    Life Sci; 2001 Jun; 69(2):181-90. PubMed ID: 11441908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem).
    Murch SJ; Rupasinghe HP; Saxena PK
    Planta Med; 2002 Dec; 68(12):1108-12. PubMed ID: 12494339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Batch-to-batch reproducibility of St. John's wort preparations.
    Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilovecz M
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S152-6. PubMed ID: 11518067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes.
    Hokkanen J; Tolonen A; Mattila S; Turpeinen M
    Eur J Pharm Sci; 2011 Feb; 42(3):273-84. PubMed ID: 21168483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Hypericum perforatum extract and its main bioactive compounds on the cytotoxicity and expression of CYP1A2 and CYP2D6 in hepatic cells.
    Silva SM; Martinho A; Moreno I; Silvestre S; Granadeiro LB; Alves G; Duarte AP; Domingues F; Gallardo E
    Life Sci; 2016 Jan; 144():30-6. PubMed ID: 26612349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical risks of St John's Wort (Hypericum perforatum) co-administration.
    Soleymani S; Bahramsoltani R; Rahimi R; Abdollahi M
    Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1047-1062. PubMed ID: 28885074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
    Gutmann H; Poller B; Büter KB; Pfrunder A; Schaffner W; Drewe J
    Planta Med; 2006 Jun; 72(8):685-90. PubMed ID: 16755466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigating the effectiveness of St John's wort herb as an antimicrobial agent against mycobacteria.
    Mortensen T; Shen S; Shen F; Walsh MK; Sims RC; Miller CD
    Phytother Res; 2012 Sep; 26(9):1327-33. PubMed ID: 22294548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a simple, rapid and reproducible HPLC assay for the simultaneous determination of hypericins and stabilized hyperforin in commercial St. John's wort preparations.
    de los Reyes GC; Koda RT
    J Pharm Biomed Anal; 2001 Dec; 26(5-6):959-65. PubMed ID: 11600308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
    Sarris J; Kavanagh DJ
    J Altern Complement Med; 2009 Aug; 15(8):827-36. PubMed ID: 19614563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. St. John's Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase Cgamma and epsilon activity.
    Galeotti N; Vivoli E; Bilia AR; Vincieri FF; Ghelardini C
    Biochem Pharmacol; 2010 May; 79(9):1327-36. PubMed ID: 20045676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
    Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
    J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypericin and hyperforin production in St. John's wort in vitro culture: influence of saccharose, polyethylene glycol, methyl jasmonate, and Agrobacterium tumefaciens.
    Pavlík M; Vacek J; Klejdus B; Kuban V
    J Agric Food Chem; 2007 Jul; 55(15):6147-53. PubMed ID: 17608493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.